Small-molecule RNA therapeutics to target prostate cancer
Cancer Cell · 2025-05 · 43 (5) · 841-855.e8
DOI: 10.1016/j.ccell.2025.02.027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2025-05. Verfasst von Duygu Kuzuoglu-Ozturk und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of California, San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University o…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Castration-Resistant, Thiohydantoins, Prostatic Neoplasms. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, American Cancer Society.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, University of California, San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA; Faculty of Engine…
- Department of Urology, University of California, San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. Electronic addres…
- Department of Urology, University of California, San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
- Department of Urology, University of California, San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA; Department of Bio…
- Department of Urology, University of California, San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA; Tetrad Graduate P…
- Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, USA.
Förderung
- NCI NIH HHS
- NIH HHS
- American Cancer Society
- US Department of Defense
- Prostate Cancer Foundation
- Portland Community Fund
- Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
- National Institutes of Health National Cancer Institute
Zitieren
APA
Kuzuoglu-Ozturk, D., Nguyen, H. G., Xue, L., Figueredo, E., Subramanyam, V., Liu, I., Bonitto, K., Noronha, A., Dabrowska, A., Cowan, J. E., Oses-Prieto, J. A., Burlingame, A. L., Worland, S. T., Carroll, P. R., & Ruggero, D. (2025). Small-molecule RNA therapeutics to target prostate cancer. Cancer Cell, 43(5), 841-855.e8. https://doi.org/10.1016/j.ccell.2025.02.027
Vancouver
Kuzuoglu-Ozturk D, Nguyen HG, Xue L, Figueredo E, Subramanyam V, Liu I, et al. Small-molecule RNA therapeutics to target prostate cancer. Cancer Cell. 2025;43(5):841-855.e8. doi:10.1016/j.ccell.2025.02.027
BibTeX
@article{KuzuogluOzturk2025,
author = {Kuzuoglu-Ozturk, Duygu and Nguyen, Hao G and Xue, Lingru and Figueredo, Emma and Subramanyam, Vishvak and Liu, Isabelle and Bonitto, Kenya and Noronha, Ashish and Dabrowska, Adrianna and Cowan, Janet E and Oses-Prieto, Juan A and Burlingame, Alma L and Worland, Stephen T and Carroll, Peter R and Ruggero, Davide},
title = {Small-molecule RNA therapeutics to target prostate cancer},
journal = {Cancer Cell},
year = {2025},
volume = {43},
number = {5},
pages = {841--855.e8},
doi = {10.1016/j.ccell.2025.02.027}
}
EUVIMED